Application of interferon regulatory factor 9 (IRF9) and inhibitor thereof in coronary arteriosclerotic heart disease
A technology of inhibitors and RNA interference, applied in the field of gene function and application, can solve problems such as not being able to meet needs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] [Example 1] Myocardial ischemia / reperfusion injury (MIRI) model was obtained
[0039] 1. Grouping of experimental animals: male C57BL / 6 strain mice (WT) and IRF9 gene knockout mice (KO) were used to create a model of myocardial ischemia / reperfusion injury by ligation of the left anterior descending coronary artery (LAD) of the mouse heart. Randomly divided into 4 groups, each group: C57BL / 6 strain mouse sham operation group (WT SHAM) and I / R operation group (WT MI), IRF9 gene knockout mouse sham operation group (KO SHAM) and I / R group surgery group (KO MI).
[0040] 2. The I / R model uses ligation of the left anterior descending coronary artery (LAD) of the mouse heart to cause myocardial ischemia / reperfusion injury. The model operation process:
[0041] 2.1 Weighing and skin preparation for anesthesia: Accurately weigh the body weight (g) of the mouse in dynamic mode with an electronic balance, accurately prepare 3% pentobarbital sodium solution with double distilled w...
Embodiment 2
[0049] [Example 2] 2,3,5-Triphenyltetrazolium chloride (2,3,5-Triphenyltetrazolium chloride, TTC)-Evans blue (Evans blue) double staining to measure myocardial infarct size
[0050] After 24 hours of ischemia-reperfusion, mice were anesthetized by intraperitoneal injection of 80 mg / kg pentobarbital sodium solution, the chest cavity was cut open, the aorta was separated, and the heart was cut together with the aorta. The needle was inserted into the root of the ascending aorta, not passing through the aortic valve, and ligated and fixed. Prepare 3-4 mL of TTC phosphate buffer (PH=7.4) at 37°C and slowly perfuse the heart from the aorta, and stop the injection when the myocardium turns brick red. Ligate the LAD again, and then perfuse about 2mL of 2.5% Evans blue evenly and slowly through the aorta, and make the myocardial ischemic area face up to prevent the outflowing Evans blue from contaminating the heart surface. After the heart turns blue, the perfusion is stopped and ful...
Embodiment 3
[0055] [Example 3] Detection of cardiac function in myocardial ischemia-reperfusion model mice
[0056] 1 PV detection of hemodynamics
[0057] 1.1 Preliminary preparation
[0058] (1) Anesthesia machine preparation: first connect the oxygen cylinder and the air inlet port on the anesthesia machine, then unscrew the sealing cap of the dosing port on the anesthesia machine, quickly add isoflurane to the safety scale, and then tighten the sealing cap. Unscrew the main valve on the oxygen cylinder, adjust the knob of the flow control valve, and maintain the outlet pressure at 0.2-0.3mPa.
[0059] (2) Preparation of the mice to be tested: After the mice to be tested were quickly anesthetized with isoflurane, the hair on the left chest area was shaved, and the head of the treated mice was inserted into the anesthetic catheter sleeve, and treated with 1.5-2.0% isoflurane Alkane maintains a stable anesthesia in mice.
[0060] 1.2 PV detection
[0061] After disinfection with iodi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com